Protective effects of omega-3 fatty acids in dogs with myxomatous mitral valve disease stages B2 and C.
Myxomatous mitral valve disease (MMVD) is characterized by thickening of the valve leaflets and omega-3 (ω-3) supplementation has been associated with modulation of blood pressure (BP) and heart rate, improvement of doppler echocardiographic indices, antiarrhythmic, anti-inflammatory and anti-dislip...
Guardado en:
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/da6e03ea3fc0404a985a4faa9bcbaa3e |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:da6e03ea3fc0404a985a4faa9bcbaa3e |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:da6e03ea3fc0404a985a4faa9bcbaa3e2021-12-02T20:09:10ZProtective effects of omega-3 fatty acids in dogs with myxomatous mitral valve disease stages B2 and C.1932-620310.1371/journal.pone.0254887https://doaj.org/article/da6e03ea3fc0404a985a4faa9bcbaa3e2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0254887https://doaj.org/toc/1932-6203Myxomatous mitral valve disease (MMVD) is characterized by thickening of the valve leaflets and omega-3 (ω-3) supplementation has been associated with modulation of blood pressure (BP) and heart rate, improvement of doppler echocardiographic indices, antiarrhythmic, anti-inflammatory and anti-dislipidemic effects in dogs and humans, although prospective studies of it single use are still absent in the veterinary literature. The objective of this study was to evaluate the influence of ω-3 supplementation in dogs with MMVD. Twenty-nine dogs were followed quarterly for 12 months by clinical evaluation, arterial blood pressure, electrocardiography, doppler echocardiography, thoracic radiography and laboratory tests including inflammatory mediators and cardiac biomarker blood concentrations. The dogs were classified in stages B2 and C, according to the classification proposed by ACVIM 2019. They were randomly assigned to either ω-3 group (ω-3G) or control group (CG). The ingestion of ω-3 reduced the chance of developing arrhythmias by 2.96 times (p = 0.003). The vertebral heart size (VHS) measurements were higher in the control group (p = 0.033). In conclusion, at the dosages used in this study, ω-3 dietary supplementation reduces the volumetric overload, has antiarrhythmic effect and keeps dogs with B2 and C stages of MMVD in milder stages of the disease.Priscilla Regina NasciuttiAline Tavares MoraesThaiz Krawczyk SantosKarine Kelly Gonçalves QueirozAna Paula Araújo CostaAndressa Rodrigues AmaralRodrigo Fernando Gomes OlivindoCristiana Ferreira Fonseca PontieriJuliana Toloi JeremiasThiago Henrique Annibale VendraminiMarcio Antonio BrunettoRosângela de Oliveira Alves CarvalhoPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 7, p e0254887 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Priscilla Regina Nasciutti Aline Tavares Moraes Thaiz Krawczyk Santos Karine Kelly Gonçalves Queiroz Ana Paula Araújo Costa Andressa Rodrigues Amaral Rodrigo Fernando Gomes Olivindo Cristiana Ferreira Fonseca Pontieri Juliana Toloi Jeremias Thiago Henrique Annibale Vendramini Marcio Antonio Brunetto Rosângela de Oliveira Alves Carvalho Protective effects of omega-3 fatty acids in dogs with myxomatous mitral valve disease stages B2 and C. |
| description |
Myxomatous mitral valve disease (MMVD) is characterized by thickening of the valve leaflets and omega-3 (ω-3) supplementation has been associated with modulation of blood pressure (BP) and heart rate, improvement of doppler echocardiographic indices, antiarrhythmic, anti-inflammatory and anti-dislipidemic effects in dogs and humans, although prospective studies of it single use are still absent in the veterinary literature. The objective of this study was to evaluate the influence of ω-3 supplementation in dogs with MMVD. Twenty-nine dogs were followed quarterly for 12 months by clinical evaluation, arterial blood pressure, electrocardiography, doppler echocardiography, thoracic radiography and laboratory tests including inflammatory mediators and cardiac biomarker blood concentrations. The dogs were classified in stages B2 and C, according to the classification proposed by ACVIM 2019. They were randomly assigned to either ω-3 group (ω-3G) or control group (CG). The ingestion of ω-3 reduced the chance of developing arrhythmias by 2.96 times (p = 0.003). The vertebral heart size (VHS) measurements were higher in the control group (p = 0.033). In conclusion, at the dosages used in this study, ω-3 dietary supplementation reduces the volumetric overload, has antiarrhythmic effect and keeps dogs with B2 and C stages of MMVD in milder stages of the disease. |
| format |
article |
| author |
Priscilla Regina Nasciutti Aline Tavares Moraes Thaiz Krawczyk Santos Karine Kelly Gonçalves Queiroz Ana Paula Araújo Costa Andressa Rodrigues Amaral Rodrigo Fernando Gomes Olivindo Cristiana Ferreira Fonseca Pontieri Juliana Toloi Jeremias Thiago Henrique Annibale Vendramini Marcio Antonio Brunetto Rosângela de Oliveira Alves Carvalho |
| author_facet |
Priscilla Regina Nasciutti Aline Tavares Moraes Thaiz Krawczyk Santos Karine Kelly Gonçalves Queiroz Ana Paula Araújo Costa Andressa Rodrigues Amaral Rodrigo Fernando Gomes Olivindo Cristiana Ferreira Fonseca Pontieri Juliana Toloi Jeremias Thiago Henrique Annibale Vendramini Marcio Antonio Brunetto Rosângela de Oliveira Alves Carvalho |
| author_sort |
Priscilla Regina Nasciutti |
| title |
Protective effects of omega-3 fatty acids in dogs with myxomatous mitral valve disease stages B2 and C. |
| title_short |
Protective effects of omega-3 fatty acids in dogs with myxomatous mitral valve disease stages B2 and C. |
| title_full |
Protective effects of omega-3 fatty acids in dogs with myxomatous mitral valve disease stages B2 and C. |
| title_fullStr |
Protective effects of omega-3 fatty acids in dogs with myxomatous mitral valve disease stages B2 and C. |
| title_full_unstemmed |
Protective effects of omega-3 fatty acids in dogs with myxomatous mitral valve disease stages B2 and C. |
| title_sort |
protective effects of omega-3 fatty acids in dogs with myxomatous mitral valve disease stages b2 and c. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2021 |
| url |
https://doaj.org/article/da6e03ea3fc0404a985a4faa9bcbaa3e |
| work_keys_str_mv |
AT priscillareginanasciutti protectiveeffectsofomega3fattyacidsindogswithmyxomatousmitralvalvediseasestagesb2andc AT alinetavaresmoraes protectiveeffectsofomega3fattyacidsindogswithmyxomatousmitralvalvediseasestagesb2andc AT thaizkrawczyksantos protectiveeffectsofomega3fattyacidsindogswithmyxomatousmitralvalvediseasestagesb2andc AT karinekellygoncalvesqueiroz protectiveeffectsofomega3fattyacidsindogswithmyxomatousmitralvalvediseasestagesb2andc AT anapaulaaraujocosta protectiveeffectsofomega3fattyacidsindogswithmyxomatousmitralvalvediseasestagesb2andc AT andressarodriguesamaral protectiveeffectsofomega3fattyacidsindogswithmyxomatousmitralvalvediseasestagesb2andc AT rodrigofernandogomesolivindo protectiveeffectsofomega3fattyacidsindogswithmyxomatousmitralvalvediseasestagesb2andc AT cristianaferreirafonsecapontieri protectiveeffectsofomega3fattyacidsindogswithmyxomatousmitralvalvediseasestagesb2andc AT julianatoloijeremias protectiveeffectsofomega3fattyacidsindogswithmyxomatousmitralvalvediseasestagesb2andc AT thiagohenriqueannibalevendramini protectiveeffectsofomega3fattyacidsindogswithmyxomatousmitralvalvediseasestagesb2andc AT marcioantoniobrunetto protectiveeffectsofomega3fattyacidsindogswithmyxomatousmitralvalvediseasestagesb2andc AT rosangeladeoliveiraalvescarvalho protectiveeffectsofomega3fattyacidsindogswithmyxomatousmitralvalvediseasestagesb2andc |
| _version_ |
1718375154227085312 |